Purdue Pharma Strikes Licensing Deal For OxyContin
Purdue Pharma LP and generics maker Mallinckrodt Inc. have struck a deal that will allow Mallinckrodt to market and sell its cheaper version of the brand-name painkiller OxyContin for a licensing...To view the full article, register now.
Already a subscriber? Click here to view full article